AMPH financials
Amphastar Pharmaceuticals (AMPH) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
AMPH income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $719.89M | $356.06M | $140.40M | $98.09M | 2.03 |
| 2024 | $731.97M | $373.86M | $205.42M | $159.52M | 3.06 |
| 2023 | $644.39M | $351.12M | $196.99M | $137.54M | 2.60 |
| 2022 | $498.99M | $248.86M | $107.50M | $91.39M | 1.74 |
| 2021 | $437.77M | $199.74M | $69.89M | $62.12M | 1.25 |
| 2020 | $349.85M | $143.34M | $10.95M | $1.40M | 0.03 |
- AMPH revenue was $719.89M in fiscal 2025, net income $98.09M.
Updated 2026-11-02 17:54 UTC